1. Home
  2. ALMS vs EQBK Comparison

ALMS vs EQBK Comparison

Compare ALMS & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • EQBK
  • Stock Information
  • Founded
  • ALMS 2021
  • EQBK 2002
  • Country
  • ALMS United States
  • EQBK United States
  • Employees
  • ALMS N/A
  • EQBK N/A
  • Industry
  • ALMS
  • EQBK Major Banks
  • Sector
  • ALMS
  • EQBK Finance
  • Exchange
  • ALMS NYSE
  • EQBK Nasdaq
  • Market Cap
  • ALMS 652.3M
  • EQBK 619.4M
  • IPO Year
  • ALMS 2024
  • EQBK 2015
  • Fundamental
  • Price
  • ALMS $9.44
  • EQBK $47.60
  • Analyst Decision
  • ALMS Strong Buy
  • EQBK Hold
  • Analyst Count
  • ALMS 6
  • EQBK 4
  • Target Price
  • ALMS $29.60
  • EQBK $42.75
  • AVG Volume (30 Days)
  • ALMS 90.9K
  • EQBK 46.4K
  • Earning Date
  • ALMS 11-13-2024
  • EQBK 10-15-2024
  • Dividend Yield
  • ALMS N/A
  • EQBK 1.29%
  • EPS Growth
  • ALMS N/A
  • EQBK N/A
  • EPS
  • ALMS N/A
  • EQBK 1.12
  • Revenue
  • ALMS N/A
  • EQBK $157,755,000.00
  • Revenue This Year
  • ALMS N/A
  • EQBK N/A
  • Revenue Next Year
  • ALMS N/A
  • EQBK $4.73
  • P/E Ratio
  • ALMS N/A
  • EQBK $41.51
  • Revenue Growth
  • ALMS N/A
  • EQBK N/A
  • 52 Week Low
  • ALMS $8.23
  • EQBK $24.92
  • 52 Week High
  • ALMS $13.53
  • EQBK $48.61
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • EQBK 64.45
  • Support Level
  • ALMS N/A
  • EQBK $44.31
  • Resistance Level
  • ALMS N/A
  • EQBK $47.98
  • Average True Range (ATR)
  • ALMS 0.00
  • EQBK 1.48
  • MACD
  • ALMS 0.00
  • EQBK 0.02
  • Stochastic Oscillator
  • ALMS 0.00
  • EQBK 85.81

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

Share on Social Networks: